ORBi: MAGIS Delphine - Neurostimulation therapies for primary headache disorders: present and future

Reference : Neurostimulation therapies for primary headache disorders: present and future


	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Neurology
	To cite this reference:	http://hdl.handle.net/2268/120111

Title :	Neurostimulation therapies for primary headache disorders: present and future
Language :	English
Author, co-author :	MAGIS, Delphine [Centre Hospitalier Universitaire de Liège - CHU > > Neurologie CHR >]
	JENSEN, Rigmor [ > > ]
	Schoenen, Jean [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Neuro-anatomie >]
Publication date :	Jun-2012
Journal title :	Current Opinion in Neurology
Publisher :	Lippincott Williams & Wilkins
Volume :	25
Issue/season :	3
Pages :	269-276
Audience :	International
ISSN :	1350-7540
e-ISSN :	1473-6551
City :	London
Country :	United Kingdom
Keywords :	[en] headache ; neurostimulation
Abstract :	[en] Purpose of review Most pharmacological treatments of primary headache disorders are partially effective and have cumbersome side effects. Therapies with better efficacy and tolerance are needed. Neurostimulation techniques may have this potential. This is an attempt to summarize the latest clinical trial results published in the field. Recent findings Hypothalamic deep brain stimulation is effective in drug-resistant chronic cluster headache (drCCH) but not riskless. Recent anatomical MRI studies indicate that the effective stimulation sites are rather widespread. Occipital nerve stimulation (ONS) seems to be effective in up to 76% of drCCH patients and its benefit long-lasting. A minority of patients are able to abandon preventive drugs. Its mechanism of action appears nonspecific. In chronic migraine, randomized controlled trials of ONS showed recently encouraging results, but long-term studies are missing. An ongoing sham-controlled trial suggests sphenopalatine ganglion neurostimulation (SPGS) efficacy in drCCH acute treatment, but possibly also in preventive therapy. Transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) modulate cortical excitability and connectivity. TMS could prevent headache when applied over the occipital cortex during the migraine aura. Repetitive TMS and tDCS have provided mixed results in a few small studies and warrant further trials. Summary Neurostimulation therapies inaugurate a new era in headache management and offer a promising alternative to medications. Future studies are necessary to provide evidence-based efficacy data, knowledge on their mode of action and information about their pharmaco-economic advantages.
Research units :	Headache Research Unit ULG
Target :	Researchers ; Professionals ; Students ; General public
Permalink :	http://hdl.handle.net/2268/120111

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	Neurostimulation in headaches - Curr Opin Neurol 2012.pdf		Publisher postprint	253.81 kB	Request copy

All documents in ORBi are protected by a user license.

Dspace v1.5